• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌患者的动态预测和预后分析:一种定标分析方法。

Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach.

机构信息

Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, P.R. China.

Department of Statistics, Jinan University, Guangzhou, P.R. China.

出版信息

Ann Epidemiol. 2020 Apr;44:45-51. doi: 10.1016/j.annepidem.2020.01.009. Epub 2020 Mar 4.

DOI:10.1016/j.annepidem.2020.01.009
PMID:32220511
Abstract

PURPOSE

Providing up-to-date information on patient prognosis is important in determining the optimal treatment strategies. The currently available prediction models, such as the Cox model, are limited to making predictions from baseline and do not consider the time-varying effects of covariates.

METHODS

A total of 1501 cervical cancer patients from the Surveillance, Epidemiology, and End Results (SEER) database were included. We introduced three landmark dynamic prediction models (models 1-3) that explore the dynamic effects of prognostic factors to obtain 5-year dynamic survival rate predictions at different prediction times. The performances of these models were evaluated by Harrell's C-index and the Brier score using cross-validation.

RESULTS

Some variables did not meet the proportional hazards assumption, indicating that the constant hazard ratios were unreliable. Model 3, which showed the best performance for prediction, was selected as the final model. Significant time-varying effects were observed for age at diagnosis, International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis, and histological subtypes. Three patients were as examples used to illustrate how the predicted probabilities change at different prediction times during follow-up.

CONCLUSIONS

Model 3 can effectively incorporate covariates with time-varying effects and update the probability of surviving an additional 5 years at different prediction times. The use of the landmark approach may provide evidence for clinical decision making by updating personalized information for patients.

摘要

目的

提供有关患者预后的最新信息对于确定最佳治疗策略非常重要。目前可用的预测模型,如 Cox 模型,仅限于从基线进行预测,并且不考虑协变量的时变效应。

方法

共纳入来自监测、流行病学和最终结果(SEER)数据库的 1501 例宫颈癌患者。我们引入了三种里程碑式的动态预测模型(模型 1-3),以探索预后因素的动态效应,从而在不同的预测时间获得 5 年的动态生存率预测。通过交叉验证,使用 Harrell 的 C 指数和 Brier 评分评估这些模型的性能。

结果

一些变量不符合比例风险假设,这表明常数风险比不可靠。表现最佳的预测模型 3 被选为最终模型。诊断时的年龄、国际妇产科联合会(FIGO)分期、淋巴结转移和组织学亚型等变量均观察到显著的时变效应。以 3 名患者为例,说明了在随访期间不同预测时间下预测概率如何变化。

结论

模型 3 可以有效地纳入具有时变效应的协变量,并在不同的预测时间更新额外存活 5 年的概率。使用里程碑方法可以通过更新患者的个性化信息为临床决策提供依据。

相似文献

1
Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach.宫颈癌患者的动态预测和预后分析:一种定标分析方法。
Ann Epidemiol. 2020 Apr;44:45-51. doi: 10.1016/j.annepidem.2020.01.009. Epub 2020 Mar 4.
2
Moving beyond the Cox proportional hazards model in survival data analysis: a cervical cancer study.超越生存数据分析中的 Cox 比例风险模型:宫颈癌研究。
BMJ Open. 2020 Jul 19;10(7):e033965. doi: 10.1136/bmjopen-2019-033965.
3
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.国际妇产科联盟(FIGO)分期、组织学类型、组织学分级、年龄和种族作为女性生殖系统癌症生存预后因素的分析:1973 - 1987年美国监测、流行病学和最终结果(SEER)项目中子宫内膜癌、宫颈癌、卵巢癌、外阴癌及阴道癌病例分析
Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46. doi: 10.1002/ssu.2980100107.
4
Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer.国际妇产科联合会(FIGO)IA2 期至 IIA 期宫颈癌中转移淋巴结的绝对数量和比值对预测术后生存的意义。
Int J Gynecol Cancer. 2013 Jan;23(1):157-63. doi: 10.1097/IGC.0b013e3182778bcf.
5
Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.分析 FIGO 早期(IA-IIA)宫颈癌手术治疗的预后变量,建立预测模型,对风险组进行分层。
Int J Gynecol Cancer. 2012 Jan;22(1):115-22. doi: 10.1097/IGC.0b013e31822fa8bb.
6
Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03).个体化预测早期宫颈癌术后放疗患者的总生存:韩国放射肿瘤学组研究(KROG 13-03)。
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):659-64. doi: 10.1016/j.ijrobp.2013.07.020.
7
The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer.基于炎症的格拉斯哥预后评分可预测宫颈癌患者的生存情况。
Int J Gynecol Cancer. 2010 Aug;20(6):1052-7. doi: 10.1111/IGC.0b013e3181e64bb1.
8
Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.年龄增长预示着宫颈癌预后不良,进而影响治疗和总体生存。
Brachytherapy. 2019 Jan-Feb;18(1):29-37. doi: 10.1016/j.brachy.2018.08.016. Epub 2018 Oct 22.
9
Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients.术前血小板计数可改善 FIGO 分期系统对可手术宫颈癌患者的预后预测。
Clin Chim Acta. 2017 Oct;473:198-203. doi: 10.1016/j.cca.2016.11.008. Epub 2016 Nov 9.
10
[Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].[新辅助化疗后行根治性子宫切除术治疗的 Ib2-IIb 期宫颈癌患者化疗前血红蛋白和血小板水平的影响]
Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):577-81.

引用本文的文献

1
Prognostic Factors for Cervical Cancer in Asian Populations: A Scoping Review of Research From 2013 to 2023.亚洲人群宫颈癌的预后因素:2013年至2023年研究的范围综述
Cureus. 2024 Oct 13;16(10):e71359. doi: 10.7759/cureus.71359. eCollection 2024 Oct.
2
Time-varying associations of patient and tumor characteristics with cancer survival: an analysis of SEER data across 14 cancer sites, 2004-2017.基于 SEER 数据的 14 个癌种 2004-2017 年肿瘤特征和患者特征与癌症生存的时变关联分析
Cancer Causes Control. 2024 Oct;35(10):1393-1405. doi: 10.1007/s10552-024-01888-y. Epub 2024 May 29.
3
Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
基于 SEER 的亚洲人群研究:宫颈癌患者预后列线图的建立和验证。
Sci Rep. 2024 Apr 1;14(1):7681. doi: 10.1038/s41598-024-57609-7.
4
Software Application Profile: dynamicLM-a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risks.软件应用程序配置文件:dynamicLM-一种使用生存数据竞争风险的里程碑超级模型进行动态风险预测的工具。
Int J Epidemiol. 2023 Dec 25;52(6):1984-1989. doi: 10.1093/ije/dyad122.
5
Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies.血液病恶性肿瘤患者血流感染的微生物学及预后预测模型。
Front Cell Infect Microbiol. 2023 Jun 30;13:1167638. doi: 10.3389/fcimb.2023.1167638. eCollection 2023.
6
Dynamic effects of prognostic factors and individual survival prediction for amyotrophic lateral sclerosis disease.肌萎缩侧索硬化症预后因素的动态影响及个体生存预测。
Ann Clin Transl Neurol. 2023 Jun;10(6):892-903. doi: 10.1002/acn3.51771. Epub 2023 Apr 4.
7
Development of a Novel Deep Learning-Based Prediction Model for the Prognosis of Operable Cervical Cancer.开发一种新型基于深度学习的可手术宫颈癌预后预测模型。
Comput Math Methods Med. 2022 Nov 26;2022:4364663. doi: 10.1155/2022/4364663. eCollection 2022.
8
Individual dynamic prediction and prognostic analysis for long-term allograft survival after kidney transplantation.肾移植后长期移植物存活的个体动态预测和预后分析。
BMC Nephrol. 2022 Nov 7;23(1):359. doi: 10.1186/s12882-022-02996-0.
9
Dynamic risk prediction of BK polyomavirus reactivation after renal transplantation.肾移植后 BK 多瘤病毒再激活的动态风险预测。
Front Immunol. 2022 Aug 17;13:971531. doi: 10.3389/fimmu.2022.971531. eCollection 2022.
10
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.宫颈癌患者个体化监测策略的年度复发风险模型。
Eur J Cancer. 2021 Oct 16;158:111-122. doi: 10.1016/j.ejca.2021.09.008.